HEALTH TOPICS 
More evidence on risks of antipsychotics in adults
Commentaries provide advice about putting the results in perspective.
Two studies provide evidence that second-generation antipsychotics increase risk of death, especially when the drugs are prescribed at high doses. Another report, on the third phase of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study, found unexpected increases in blood sugar levels among patients taking aripiprazole (Abilify).
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise